The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer

Immunotherapy of metastatic renal cell carcinoma

(2010) David F. McDermott   CANCER

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases

(2009) Johnny Kao et al.   CANCER

Development of Sunitinib in Hepatocellular Carcinoma: Rationale, Early Clinical Experience, and Correlative Studies

(2009) Andrew X. Zhu et al.   CANCER JOURNAL

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

(2009) J. S. Ko et al.   CLINICAL CANCER RESEARCH

Vascular Endothelial Growth Factor Pathway—Targeted Therapy as Initial Systemic Treatment of Patients with Renal Cancer

(2009) Elizabeth K. Chung et al.   Clinical Genitourinary Cancer

Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma

(2009) Robert J. Motzer et al.   Clinical Genitourinary Cancer

Gastrosplenic Fistula From Hodgkin's Lymphoma

(2009) Carolyn D. Seib et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapy

(2009) Michael B. Atkins   MEDICAL ONCOLOGY

Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

(2008) J. H. Finke et al.   CLINICAL CANCER RESEARCH

Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma

(2008) Brian I. Rini et al.   JOURNAL OF CLINICAL ONCOLOGY